Canadian natural health products system
This article was originally published in The Tan Sheet
Executive Summary
Labeling, product/site licensing, GMPs, adverse event reporting, definitions and clinical trials are among provisions in proposed regulatory framework slated for publication in Canada Gazette Dec. 22. Proposed regs, announced by Health Canada Dec. 20, follow agency's establishment of Natural Health Products Directorate in 1999 (1"The Tan Sheet" Nov. 30, 1998, p. 6). Comments on proposed measures will be accepted for 90 days...
You may also be interested in...
Canada Natural Health Products New Regulatory Scheme Proposed
Canada's House of Commons Standing Committee on Health recommends the government create a new regulatory division for natural health products reporting to the Assistant Deputy Minister of the Health Protection Branch.
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.